Skip to main content
. 2015 Jun 5;5(6):e007527. doi: 10.1136/bmjopen-2014-007527

FigureĀ 5.

FigureĀ 5

Sensitivity analysis: probability that ranibizumab monotherapy is the most efficacious treatment based on best corrected visual acuity (BCVA) letters gained from baseline.